| Literature DB >> 11087791 |
T Chapman1, D W McKeel, J C Morris.
Abstract
The definitive diagnosis of Creutzfeldt-Jakob disease (CJD) requires brain tissue analysis. A positive assay for the 14-3-3 protein in CSF has been suggested to be highly sensitive and specific in patients with CJD. The authors describe three patients for whom CSF 14-3-3 assays were falsely positive or falsely negative. Caution against overreliance on this putative biomarker is suggested in the diagnosis of CJD.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11087791 DOI: 10.1212/wnl.55.9.1396
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910